Calcitriol

For research use only.

Catalog No.S1466 Synonyms: RO215535, Topitriol, 1,25-Dihydroxyvitamin D3

30 publications

Calcitriol Chemical Structure

CAS No. 32222-06-3

Calcitriol (RO215535, Topitriol, 1,25-Dihydroxyvitamin D3) is a nonselective vitamin D receptor activator/agonist(VDRA), exhibiting a 10-fold higher vitamin D receptor (VDR) binding affinity(IC50=0.4 nM) than the selective VDRA paricalcitol. Solutions are best fresh-prepared.

Size Price Stock Quantity  
10mM (1mL in DMSO) RMB 4083.92 In stock
RMB 982.44 In stock
RMB 2231.47 In stock
RMB 8763.30 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's Calcitriol has been cited by 30 publications

Purity & Quality Control

Choose Selective Vitamin Inhibitors

Biological Activity

Description Calcitriol (RO215535, Topitriol, 1,25-Dihydroxyvitamin D3) is a nonselective vitamin D receptor activator/agonist(VDRA), exhibiting a 10-fold higher vitamin D receptor (VDR) binding affinity(IC50=0.4 nM) than the selective VDRA paricalcitol. Solutions are best fresh-prepared.
Targets
vitamin D receptor [1]
(Cell-free assay)
In vitro

Calcitriol is a potent inhibitor of PHA-induced lymphocyte proliferation, achieving 70% inhibition of tritiated thymidine incorporation after 72 h in culture. Calcitriol suppresses interleukin-2 (IL-2) production by PHA-stimulated peripheral blood mononuclear cells in a concentration-dependent fashion. [1] Calcitriol increases the concentration of intracellular calcium ([Ca2+]i) within 5 s by mobilizing calcium from the endoplasmic reticulum and the formation of inositol 1,4, 5-trisphosphate and diacylglycerol. [2] Calcitriol can inhibit the proliferation and promote the differentiation of human prostate adenocarcinoma cells. Calcitriol causes a selective decrease in the secreted levels of type IV collagenases (MMP-2 and MMP-9). [3] Calcitriol has antiproliferative activity in squamous cell carcinoma and prostatic adenocarcinoma and enhances the antitumor activity of platinum-based agents. Calcitriol prior to paclitaxel significantly reduces clonogenic survival compared with either agent alone in the murine squamous cell carcinoma and PC-3 cells. [4] Calcitriol is a potent anti-proliferative agent in a wide variety of malignant cell types. Calcitriol effects are associated with an increase in G0/G1 arrest, induction of apoptosis and differentiation, modulation of expression of growth factor receptors. Calcitriol potentiates the antitumor effects of many cytotoxic agents and inhibits motility and invasiveness of tumor cells and formation of new blood vessels. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
human HCT116 MXLDfZRwfG:6aXRCpIF{e2G7 NGDFcJEyOjBiaB?= MonkR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gTGNVOTF4IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKGOnbHygZ492dnRiYX\0[ZIhOTJyIHjyd{whUUN3ME2x[U0xPSEQvF2= MlnZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ7Mk[wOlgoRjJ{OUK2NFY5RC:jPh?=
HOS MnzTSpVv[3Srb36gZZN{[Xl? NEjDR5ZC[3Srdnn0fUBifCCqdX3hckBXTFJiZYjwdoV{e2WmIHnuJIh2dWGwIFjPV{Bk\WyuczD0doFve2[nY4Tl[EB4cXSqIIDHUFMucE:lLDDwR2RPSS2qVlTSJIFv\CCyaGLMMXRMKGG|c3Xzd4VlKGG|IHHzd4V{e2WmIHHzJJRz[W6|Y4LpdJRqd26jbDDhZ5RqfmG2aX;uJI1m[XO3cnXkJFI1KGi{czDwc5N1KGmwZnXjeIlwdiCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUCgQUAxNjByMECxJO69VS5? NVn5dnpwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG4PFk{OzRpPkKxPFg6OzN2PD;hQi=>
SK-MEL-188 NI[1RXJIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NX;RTotqPDhiaILz NH;kcphIem:5dHigbY5pcWKrdHnvckBw\iCqdX3hckBUUy2PRVytNVg5KGOnbHzzJI1m[XO3cnXkJIFnfGW{IES4JIhzeyCkeTDNWHMwWE2VIHHzd4F6NCCLQ{WwJF0hOC5yMECwNUDPxE1w MnjaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjdyN{C3O|koRjJ5MEewO|c6RC:jPh?=
osteosarcoma cells NWmzO3E3TnWwY4Tpc44h[XO|YYm= NF3SO4lG\m[nY4Sgc44hXkSUIITyZY5{[3KrcITpc45idCCjY4Tpeol1gSCrbjDoeY1idiCxc4Tlc5NiemOxbXGgZ4VtdHNuIFXDOVAhRSByLkCwNFAyODZizszNMi=> NH3w[2w9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEC1OFI{OCd-MUiwOVQzOzB:L3G+
HOS/SF M1rhN2Z2dmO2aX;uJIF{e2G7 Mo\CNlQhcHK| NI\NOnNVemGwc3HjeIl3[XSrb36gc4YhXkSULX3l[IlifGWmIH;zeIVw[2GuY3nuJJBzd22xdHXyJIlvKGi3bXHuJGhQWy:VRjDj[YxteyCjZoTldkAzPCCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxKD1iMD6wNFAxOjZizszNMi=> NUn4T4RuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFA4OjhpPkK0PVAxPzJ6PD;hQi=>
LM05e MmPqRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NGTI[Zg4OiCqcoO= NXTHUIVjSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBud3W|ZTDMUVA2\SClZXzsd{Bie3Onc4Pl[EBieyCmZXPy[YF{\SCrbjDj[YxtKG63bXLldkBi\nSncjC3NkBpenNiYomgW3NVKGG|c3H5MEBKSzVyIE2gNE4xODByMzFOwG0v NIXEOXk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEmwNFM{QSd-MkS5NFA{Ozl:L3G+
HEK293 MojrSpVv[3Srb36gZZN{[Xl? NYDuV2FWXHKjboPy[ZBz\XO|aX;uJI9nKF[SMU[teIFo\2WmIG\EVkApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgbIFz[m:{aX7nJJBEVVhvR1HMOE1PS2:UIHHu[EBOUDFyMDjVRXMqKFhiNITrMWxWSyC{ZYDvdpRmeiCybHHzcYllKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJG5Ed1JicnXjdpVqfG2nboSgZpkh[mW2YT3nZYxi[3Sxc3nkZZNmKHKncH;yeIVzKGenbnWgZoF{\WRibXHtcYFtcWGwIIT3c{1pgWK{aXSgZZN{[XluIFnDOVAhRSByLkCwNFA2KM7:TT6= NVL2SWNWRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm5PFk5OTdpPkK5PVg6QDF5PD;hQi=>
HEK293 NVPNeFlITnWwY4Tpc44h[XO|YYm= M1zJcXRz[W6|YXP0bZZifGmxbjDv[kBXWDF4LYTh[4dm\CCYRGKgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHjhdoJwemmwZzDwR21ZNUeDTEStVnhT[WyyaHGgZY5lKE2KMUCwLHVCWyliWDC0eIsuVFWFIILldI9zfGW{IIDsZZNucWRiYYPz[ZN{\WRiYYOgbY5kemWjc3WgbY4hcW62ZYLhZ5Rqd25id3n0bEBTYFKjbIDoZUBjgSCkZYThMYdidGGldH;zbYRie2VicnXwc5J1\XJiZ3Xu[UBj[XOnZDDtZY1u[WyrYX6geJdwNSxiRVO1NEA:KDBwMECwNFch|ryPLh?= MXS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTl6OUixO{c,Ojl7OEm4NVc9N2F-
HEK293T NFPMR5RHfW6ldHnvckBie3OjeR?= Ml\xRYdwdmm|dDDhZ5Rqfmm2eTDheEBISUx2IFTORU1jcW6maX7nJIRwdWGrbjDmeZNm\CCYRGKgLJVvc26xd36gc5Jq\2mwKTDsbYdidmRiYnnu[Ilv\yCmb33hbY4h\XiycnXzd4VlKGmwIGXBV{1jdGFiSFXLJFI6O1RiY3XscJMh[XO|ZYPz[YQh[XNiYnX0ZU1t[WO2YX3hd4UhfHKjboPjdolxfGmxbnHsJIFkfGm4YYTpc44h[nliRmLFWE1j[XOnZDDH[Y5mSkyDenXyJIF{e2G7LDDJR|UxKD1iMD6wNFAxQTV|IN88UU4> MnzlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzNES2PVcoRjNyMUS0Olk4RC:jPh?=
HEK293 NIrIS2RHfW6ldHnvckBie3OjeR?= M3TkO2Fod26rc4SgZYN1cX[rdImgZZQhXkSUIDj1cotvd3ewIH;ybYdqdiliZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyClb4TyZY5{\mWldHXkJJdqfGhiTlPvVkBie3Onc4Pl[EBieyCmZXPy[YF{\SCrbjDOR49TKHKnY4L1bZRu\W62IHL5JJR4dy2qeXLybYQh[XO|YYmsJGlEPTBiPTCwMlAxODFizszNMi=> M2jlRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NkGzOFIxLz5{Nk[xN|QzODxxYU6=
HEK293 NHfvWXJHfW6ldHnvckBie3OjeR?= MXSxOkB1dyB{NDDodpM> MXrB[49vcXO2IHHjeIl3cXS7IHH0JHZFWiCrbjDoeY1idiCKRVuyPVMh[2WubIOgZZN{\XO|ZXSgZZMhfHKjboPjdolxfGmxbnHsJIFkfGm4aYT5JIFnfGW{IEG2JJRwKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTBiPTCwMlAxODF{IN88UU4> M33XTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NkGzOFIxLz5{Nk[xN|QzODxxYU6=
ROS 17/2.8 MWPGeY5kfGmxbjDhd5NigQ>? MV6xOkBpenN? MkTrRYN1cX[rdImgZZQhXkSUIHnuJJJifCCUT2OgNVcwOi56IHPlcIx{KGG|c3Xzd4VlKGG|IITyZY5{[3KrcITpc45idCCjY4TpeoF1cW:wIH;mJFI1NWi7ZILvfJlt[XOnIHflcoUheHKxbX;0[ZIh[W[2ZYKgNVYhcHK|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NEA:KDBwMECwNkDPxE1w NH;sOGc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUG2O|g6Oyd-MUmxOlc5QTN:L3G+
osteosarcoma cells MnX6SpVv[3Srb36gZZN{[Xl? MmriRYN1cX[rdImgZZQhXkSUIHnuJJJifCCxc4Tlc5NiemOxbXGgZ4VtdHNiYYPz[ZN{\WRiYYOgNlQucHmmcn;4fYxie2VidILhcpNkemmydHnvckBjgSC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxKD1iMD6wNFAzKM7:TT6= MmLvQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd7NkC5NlQoRjF5OU[wPVI1RC:jPh?=
ROS 17/2.8 MlXuSpVv[3Srb36gZZN{[Xl? NX7GWHREOTZiaILz MVfBZ5Rqfmm2eTDheEBz[XRicnXjc41jcW6jboSg[pVtdCCuZX7neIghXkSUIHX4dJJme3OnZDDpckBz[XRiUl;TJFE4NzJwODDj[YxteyC2cnHud4Zm[3SnZDD3bZRpKDJ2LXj5[JJwgHmuYYPlJIdmdmVicILvcY91\XJiYYPz[ZN{\WRiYYOgeJJidnOlcnnweIlwdmGuIHHjeIl3[XSrb36gZYZ1\XJiMU[gbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3MDC9JFAvODByMjFOwG0v M4X2e|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6N{KyNVMxLz5zOEeyNlE{ODxxYU6=
ROS 17/2.8 M17X[mZ2dmO2aX;uJIF{e2G7 NH2xWZQyPiCqcoO= NXi3O4NPSWO2aY\peJkh[XRicnH0JJJm[2:vYnnuZY51KG[3bHygcIVv\3SqIG\EVkBmgHC{ZYPz[YQhcW5icnH0JHJQWyBzNz:yMlgh[2WubIOgeJJidnOoZXP0[YQhf2m2aDCyOE1pgWS{b4j5cIF{\SCpZX7lJJBzd22xdHXyJIF{e2W|c3XkJIF{KHS{YX7zZ5JqeHSrb37hcEBi[3SrdnH0bY9vKGGodHXyJFE3KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFvpJF0hOC5yMECyJO69VS5? NUfYN5cyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGxNFU3PzdpPkKxNVA2Pjd5PD;hQi=>
ROS 17/2.8 NV\RZWZZTnWwY4Tpc44h[XO|YYm= NIjCN44yPiCqcoO= MWPB[49vcXO2IHHjeIl3cXS7IHH0JJJifCCYRGKgbY4hWk:VIEG3M|IvQCClZXzsd{B1emGwc3\lZ5Rm\CC5aYToJGN6eDJ2YUGgdoVxd3K2ZYKgdIxie22rZDDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCFeYCyOIEyKHS{YX7zZ5JqeHSrb36gZYZ1\XJiMU[gbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3MDC9JFAvODByMjFOwG0v MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjBzOEmxPEc,OjJyMUi5NVg9N2F-
osteosarcoma cells M4SxcmZ2dmO2aX;uJIF{e2G7 NYPROZhJUW6mdXP0bY9vKG:oIG\EVk1u\WSrYYTl[EAzPC2qeXTyc5h6dGG|ZTD0doFve2O{aYD0bY9vKGmwIILheEBwe3Snb4PhdoNwdWFiY3XscJMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGTDVyIE2gNE4xODB{IN88UU4> MkPyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF7MEKyN|UoRjJzOUCyNlM2RC:jPh?=
osteosarcoma cells NU\iR4lqTnWwY4Tpc44h[XO|YYm= M2Twd3Rz[W6|YXP0bZZifGmxbjDv[kBXTFJiaX6gdoF1KG:|dHXvd4Fz[2:vYTDj[YxteyCjc4Pld5Nm\CCjczCyOE1pgWS{b4j5cIF{\SC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGTDVyIE2gNE4xODB{IN88UU4> M2f3NlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NkOwOFQ1Lz5{Nk[zNFQ1PDxxYU6=
osteosarcoma cells NFq0ZoZHfW6ldHnvckBie3OjeR?= M3GyfVE3KGi{cx?= MXLJcohq[mm2aX;uJI9nKF[GUj3pcoR2[2WmIEK0MYh6\HKxeInsZZNmKHS{YX7zZ5JqeHSrb36gbY4hemG2IH;zeIVwe2G{Y3;tZUBk\WyuczDh[pRmeiBzNjDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGTDVyIE2gNE4xODB{IN88UU4> Mmq2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ2OUCwNVAoRjJ{NEmwNFExRC:jPh?=
osteosarcoma cells NWn0NYRHTnWwY4Tpc44h[XO|YYm= MoDTRYN1cX[rdImgZZQhXkSUIHnuJJJifCCxc4Tlc5NiemOxbXGgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5lfWO2aX;uJI9nKDJ2LXj5[JJwgHmuYYPlJJJmeG:{dHXyJIdmdmVidILhcpNkemmydHnvckBjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTBiPTCwMlAxODNizszNMi=> NYfuWJptRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm4NVk4ODJpPkG5PFE6PzB{PD;hQi=>
HuH7 NXK2WolCTnWwY4Tpc44h[XO|YYm= M3HnUVI1KGi{cx?= M2TvV2Fod26rc4SgZYN1cX[rdImgZZQhXkSUIHX4dJJme3OnZDDpckBpfW2jbjDIeWg4KGOnbHzzJIFnfGW{IEK0JIhzeyCkeTDwSHI{NWy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OCB;IECuNFAxOyEQvF2u NV7qRZZzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkexOFUxPzFpPkK3NVQ2ODdzPD;hQi=>
ROS 17/2.8 MYLGeY5kfGmxbjDhd5NigQ>? MlXHWol1[W2rbjDEN{Bz\WOncITvdk1u\WSrYYTl[EB1emGwc3PybZB1cW:wYXygdI91\W6leTDpckBz[XRib4P0[Y9{[XKlb33hJHJQWyBzNz:yMlgh[2WubIOsJGVFPTBiPTCwMlAxODN3IN88UU4> Ml33QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTB2N{myO|YoRjFyNEe5Nlc3RC:jPh?=
ROS 17/2.8 NGDISppHfW6ldHnvckBie3OjeR?= MXzJckB3cXS{bzD2bZRidWmwIFSgdoVk\XC2b4KgLHZFWilvbXXkbYF1\WRidILhcpNkemmydHnvcoFtKHCxdHXuZ5khcW5icnH0JI9{fGWxc3HyZ49u[SCUT2OgNVcwOi56IHPlcIx{NCCHREWwJF0hOC5yMECzOkDPxE1w NGKzeok9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMUCwNFAyPCd-MUGwNFAxOTR:L3G+
ROS 17/2.8 NYDmWplRTnWwY4Tpc44h[XO|YYm= NFLGXoxKdiC4aYTyc{B3cXSjbXnuJGQhemWlZYD0c5IudWWmaXH0[YQh[W62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkhcW5icnH0JI9{fGWxc3HyZ49u[SCUT2OgNVcwOi56IHPlcIx{NCCHREWwJF0hOC5yMEC0JO69VS5? MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOTl|MU[yO{c,OTF7M{G2Nlc9N2F-
COS7 NG\ISZVHfW6ldHnvckBie3OjeR?= MX\JcoR2[3Srb36gc4YhfHKjboPhZ5RqfmG2aX;uJI9nKGi3bXHuJHZFWiC{ZYPwc45{cX[nIHflcoUhcW5iQ1;TO{Bk\WyuczDifUBz[XRib4P0[Y9xd262aX6gcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwJF0hOC5yMEC1JO69VS5? NVfYe4cyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUeyPVgxPDVpPkG3Nlk5ODR3PD;hQi=>
COS7 M1vaVWZ2dmO2aX;uJIF{e2G7 NXHVUHZbOjRiaILz MoHwRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDWSHIhcW5iQ1;TO{Bk\WyuczDhd5Nme3OnZDDhd{BqdmS3Y4Tpc44hd2ZidILhcpNkemmydHnvcoFtKHS{YX7zZYN1cX[jdHnvckBi\nSncjCyOEBpenNiYomgcY92e2Vib4P0[Y9xd262aX6gcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwJF0hOC5yMEC1JO69VS5? MmnJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd7MESzO|AoRjF5OUC0N|cxRC:jPh?=
SVEC MUjBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NFLpUYc4OiCqcoO= NYjsd4xuSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBud3W|ZTDTWmVEKGOnbHzzJIF{e2W|c3XkJIF{KGSnY4LlZZNmKGmwIHPlcIwhdnWvYnXyJIFnfGW{IEeyJIhzeyCkeTDXV3Qh[XO|YYmsJGlEPTBiPTCwMlAxODV{IN88UU4> MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEOzPUc,OjR7MECzN|k9N2F-
osteosarcoma cells MW\GeY5kfGmxbjDhd5NigQ>? MnHUSYZn\WO2IH;uJHZFWiC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkhcW5iaIXtZY4hd3O2ZX;zZZJkd22jIHPlcIx{KGmwIIDy[ZNmdmOnIH;mJFUmKG[ndHHsJINidGZic3XyeY0tKEWFNUCgQUAxNjByMEW1OUDPxE1w MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDB3NEKzNEc,OThyNUSyN|A9N2F-
HEK293 M{TiPGZ2dmO2aX;uJIF{e2G7 MX7B[49vcXO2IHHjeIl3cXS7IHH0JHZFWiBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[2:2cnHud4Zm[3SnZDD3bZRpKFK[UnHsdIhiKGG|c3Xzd4VlKGG|IGLYVoFteGijIILlZ5J2cXSvZX70JIJ6KHS5bz3ofYJzcWRiYYPzZZktKEWFNUCgQUAxNjByME[g{txONg>? NILOb|E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Nk[xN|QzOCd-Mk[2NVM1OjB:L3G+
CV1 NEPVdWVHfW6ldHnvckBie3OjeR?= NH;FXmZC[3Srdnn0fUBwdiCqdX3hckBXTFJvbXXkbYF1\WRidILhcpNkemmydHnvckBw\iCxc4Tlc4NidGOrbjDWSHJGKG[3c3XkJJRwKHSqeX3p[Ilv\SCtaX7hd4UheHKxbX;0[ZIw\3Kxd4ToJIhwem2xbnWgdoVxd3K2ZYKg[4Vv\SCrbjDDWlEh[2WubIOsJGVFPTBiPTCwMlAxODdizszNMi=> MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzF2OUi4NEc,OTdzNEm4PFA9N2F-
NHEK MVLBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MX6yOEBpenN? NV3jWWF2SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBPUEWNIHPlcIx{KGmwY4XiZZRm\CCob4KgNlQhcHK|IHL5JHs{UF22aIntbYRqdmViaX7jc5Jxd3KjdHnvckBie3OjeTygSWM2OCB;IECuNFAxPzJ6IN88UU4> MXq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjRyNEOyOkc,OjJ2MESzNlY9N2F-
COS1 MWfGeY5kfGmxbjDhd5NigQ>? Ml\RSIl{eGyjY3Xt[Y51KG:oIEGtZYxxcGFuIEK1MUhQUCmdM1jdSFMh\nKxbTDoeY1idiCYRGKg[ZhxemW|c3XkJIlvKEORU{GgZ4VtdHNuIFnDOVAhRSByLkCwNFgh|ryPLh?= NYnw[Yx7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe5NlQ3OTZpPkG3PVI1PjF4PD;hQi=>
HEK293 M17peWZ2dmO2aX;uJIF{e2G7 MX2yOEBpenN? MmHSRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDWSHIhcW5iSFXLNlk{KGOnbHzzJIF{e2W|c3XkJIF{KGmwZIXjeIlwdiCxZjD0doFve2O{aYD0bY9v[WxidILhcpNi[3SrdnH0bY9vKGGodHXyJFI1KGi{czDifUBud3W|ZTDvd5Rmd3CxboTpckBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVAhRSByLkCwNUDPxE1w M4D3[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5OUC0N|cxLz5zN{mwOFM4ODxxYU6=
HL60 NHvYUG5HfW6ldHnvckBie3OjeR?= M2HlW2lv\HWldHnvckBw\iCqdX3hckBJVDZyIHTp[oZmemWwdHnheIlwdiCjc4Pld5Nm\CCjczDj[YxteyC{ZXT1Z4lv\yCwaYTyc{BjdHWnIITleJJigm:uaYXtMEBGTDVyIE2gNE4xODFizszNMi=> NWnDNoFwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG5NFIzOzVpPkKxPVAzOjN3PD;hQi=>
HeLa NHe1VZVHfW6ldHnvckBie3OjeR?= MkS1NVYhcHK| MlXwWJJidnOjY4TpeoF1cW:wIH;mJGdCVDRvZoXz[YQhXkSUIHzp[4Fv\CCkaX7kbY5oKGSxbXHpckBmgHC{ZYPz[YQhcW5iaIXtZY4hUGWOYTDj[YxteyCjZoTldkAyPiCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxKD1iMD6wNFEh|ryPLh?= M2jWd|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OUW3PFM1Lz5{Mkm1O|g{PDxxYU6=
T47D NG\IcWhCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NIjCd3M4OiCqcoO= M1zae2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVES3SEBk\WyuczDhd5Nme3OnZDDhd{Bl\WO{ZXHz[UBqdiClZXzsJI52dWKncjDh[pRmeiB5MjDodpMh[nliV2PUJIF{e2G7LDDJR|UxKD1iMD6wNFE{KM7:TT6= NVn3d4c5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFA{OzlpPkK0PVAxOzN7PD;hQi=>
ROS 17/2.8 MX3GeY5kfGmxbjDhd5NigQ>? NIDaS|ZC[3Srdnn0fUBifCCqdX3hckBz\WOxbXLpcoFvfCCYRGKgbY4hWk:VIEG3M|IvQCClZXzsd{B1emGwc3\lZ5Rm\CC5aYToJIdzd3e2aDDoc5Jud26nIH\1d4lwdiCpZX7lJHZFWkViYYPz[ZN{\WRiYYOg[5Jwf3SqIHjvdo1wdmVibHX2[Ywh[nlidILhcpNkemmydHnvcoFtKGG|c3H5MEBGTDVyIE2gNE4xODF3IN88UU4> NWnKd5l7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe5NlQ3OTZpPkG3PVI1PjF4PD;hQi=>
HEK293 NX7abHVLTnWwY4Tpc44h[XO|YYm= MXWyOEBpenN? MXLUdoFve2GldHn2ZZRqd25ib3[gdoVkd22kaX7hcpQhcHWvYX6gWmRTN1K[UnHsdIhiKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[W[2ZYKgNlQhcHK|IHL5JGR2[WxvbIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyIE2gNE4xODF3ODFOwG0v MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF7M{KxOkc,OzBzOUOyNVY9N2F-
MCF7 NH[zZ|BHfW6ldHnvckBie3OjeR?= M37KNFI1KGi{cx?= NFrEVmRC\2:waYP0JIFkfGm4aYT5JIF1KF[GUjDpckBpfW2jbjDNR2Y4KGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIITyZY5{[3KrcITpc44hd2ZiQ2nQNlRCOSCpZX7lJIFnfGW{IEK0JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUCgQUAxNjByMU[g{txONg>? Mmq5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl5M{O2OFUoRjJ7N{OzOlQ2RC:jPh?=
MCF10DCIS.com NXPM[oVRSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= Mk\VN{Bl[Xm| NYK2bXE{SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBGWiCyb4PpeIl3\SCqdX3hckBOS0ZzMFTDTXMv[2:vIHPlcIx{KGGodHXyJFMh\GG7czDifUBcO0ifdHj5cYllcW6nIIXweIFs\SCjc4PhfUwhUUN3MDC9JFAvODBzN{Wg{txONg>? M{mwb|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MUiwPFM4Lz5{MkG4NFg{PzxxYU6=
HL60 MYTGeY5kfGmxbjDhd5NigQ>? NGHaV2JKdmS3Y4Tpc44hd2ZiZHnm[oVz\W62aX;uJI9nKGi3bXHuJGhNPjBiY3XscJMhcW62bzDtc45w[3m2ZYOgZpkhVkKWIILl[JVkfGmxbjDhd5NigSxiRVO1NEA:KDBwMECyJO69VS5? M2L6WlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5OU[wPVI1Lz5zN{m2NFkzPDxxYU6=
HL-60 MkTFSpVv[3Srb36gZZN{[Xl? MnXTOEBl[Xm| MmG1TY5lfWO2aX;uJI9nKGSrZn\ldoVvfGmjdHnvckBw\iCqdX3hckBJVC14MDDj[YxteyCycn;tfYVtd2O7dHXzJJRwKG2xbn;jfZRmeyCjZoTldkA1KGSjeYOgZpkhVkKWIILl[JVkfGmxbjDhd5NigSxiRVO1NEA:KDBwMECyJO69VS5? MkDCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh5MkKxN|AoRjF6N{KyNVMxRC:jPh?=
bone marrow cells NVzUc4hLTnWwY4Tpc44h[XO|YYm= M1LWUFMh\GG7cx?= NV\5dHdLTW[oZXP0JI9vKG:|dHXvZ4xie3RiZn;ycYF1cW:wIHnuJIRlYSCvb4Xz[UBjd26nIH3hdpJwfyClZXzsd{BkdyCldXz0eZJm\CC5aYToJJBzcW2jcomgc5N1\W:lbHHzeJMh[W[2ZYKgN{Bl[Xm|LDDFR|UxKD1iMD6wNFIh|ryPLh?= MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDV|OUCzOEc,OTh3M{mwN|Q9N2F-
HL60 M1e1OGZ2dmO2aX;uJIF{e2G7 NFLk[FE1KGSjeYO= NXK0U5hbUW6mdXP0bY9vKG:oIHTp[oZmemWwdHnheIlwdiCxZjDoeY1idiCKTE[wJINmdGy|IIDyc416\WyxY4n0[ZMhfG9ibX;uc4N6fGW|IHHmeIVzKDRiZHH5d{BjgSCQQmSgdoVlfWO2aX;uJIF{e2G7LDDLbUA:KDBwMECyJO69VS5? NHvCfnE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGwOVY4Pyd-MkGxNFU3Pzd:L3G+
HeLa NWjXb3RkTnWwY4Tpc44h[XO|YYm= NHK0SXEyQCCqcoO= MkSzWJJidnOjY4TpeoF1cW:wIH;mJIZ2dGxibHXu[5RpKGi3bXHuJHZFWiCneIDy[ZN{\WRiaX6gbJVu[W5iSHXMZUBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCFWWCyOEB1emGwc3PybZB1cW:wIHHmeIVzKDF6IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTBiPTCwMlAxOjVizszNMi=> MkLJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ7NUe4N|QoRjJ{OUW3PFM1RC:jPh?=
PBMC NYHlXmNpTnWwY4Tpc44h[XO|YYm= NUn5OXl4UW5idnn0do8hcW6qaXLpeIlwdiCxZjDwbJl1d2inbXHn[4x2fGmwaX7pck1qdmS3Y3XkJJN1cW23bHH0bY9vKG:oIHj1cYFvKHCncnnwbIVz[WxiYnzvc4QhdW:wb371Z4xm[XJiY3XscJMheHKxbHnm[ZJifGmxbjygSWQ2OCB;IECuNFAzPyEQvF2u Mm\SQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTFyMECwNVQoRjFzMECwNFE1RC:jPh?=
HL60 NIP3c45HfW6ldHnvckBie3OjeR?= M1Tyemlv\HWldHnvckBw\iClZXzsJIRq\m[ncnXueIlifGmxbjDv[kBpfW2jbjDIUFYxKGOnbHzzJJRwKG2xbn;jfZRmeyCkeTDORnQhemWmdXP0bY9vKGG|c3H5MEBGSzVyIE2gNE4xODNizszNMi=> M1PqdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7MU[3PFk{Lz5zOUG2O|g6OzxxYU6=
HEK293 MYfGeY5kfGmxbjDhd5NigQ>? M{nJbWFod26rc4SgZYN1cX[rdImgZZQhS02[LVfBUFQhfGGpZ3XkJIh2dWGwIG\EVkBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIITyZY5{[3KrcITpc45idCCjY4Tpeol1gSCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUCgQUAxNjByMzFOwG0v NEPyeIs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{S2NlcyPSd-MkO0OlI4OTV:L3G+
MCF7 NW\BXZBMTnWwY4Tpc44h[XO|YYm= NH25dpMzPCCqcoO= NWfKeZlKSWexbnnzeEBi[3Srdnn0fUBifCCYRGKgbY4hcHWvYX6gUWNHPyClZXzsd{Bie3Onc4Pl[EBieyC2cnHud4NzcXC2aX;uJI9nKEO\UEK0RVEh\2WwZTDh[pRmeiB{NDDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyIE2gNE4xODN{ODFOwG0v M1rwTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OUi5N|c6Lz5{Mkm4PVM4QTxxYU6=
Caco-2 NIXl[GJHfW6ldHnvckBie3OjeR?= NGnkVnNG\m[nY4Sgc44hXkSUIITyZY5{[3KrcITpc45idCCjY4Tpeol1gSCrbjDoeY1idiCFYXPvMVIh[2WubIOgbY4heHKnc3XuZ4Uhd2ZiNTWg[oV1[WxiY3Hs[kB{\XK3bTygSWM2OCB;IECuNFA{PTJizszNMi=> MlHGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOThyNUSyN|AoRjF6MEW0NlMxRC:jPh?=
MCF10AT1 NGrrV5pCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NGnpdWM{KGSjeYO= MWrBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IFXSJJBwe2m2aY\lJIh2dWGwIF3DSlExSVRzIHPlcIx{KGGodHXyJFMh\GG7czDifUBcO0ifdHj5cYllcW6nIIXweIFs\SCjc4PhfUwhUUN3MDC9JFAvODB|OTFOwG0v NWnmdmVMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKxPFA5OzdpPkKyNVgxQDN5PD;hQi=>
Jurkat Mn7PSpVv[3Srb36gZZN{[Xl? MnfkNlQhcHK| MU\BZ5RqfmG2aX;uJI9nKF[GUjDpckBpfW2jbjDKeZJs[XRiY3XscJMh\XiycnXzd4lv\yCuZX70bZZqemGuIG\EVmUudHWlaX\ldoF{\SC4ZXP0c5Ih[XO|ZYPz[YQh[XNiVlTSSU1u\WSrYYTl[EB1emGwc3PybZB1cW:wYXygZYN1cX[rdImgcYVie3W{ZXSgZYZ1\XJiMkSgbJJ{KGK7IHz1Z4ln\XKjc3WgeJJidnOlcnnweIlwdmGuIILldI9zfGW{IHHzd4F6NCCHQ{WwJF0hOC5yMEO5N|Yh|ryPLh?= M1HZPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5MEewO|c6Lz5{N{C3NFc4QTxxYU6=
MCF7 NFXFWnhHfW6ldHnvckBie3OjeR?= M1PXZmFod26rc4SgZYN1cX[rdImgZZQhgmWkcnHmbZNpKGejbEStWmRTKEyERDDlfJBz\XO|ZXSgbY4hcHWvYX6gUWNHPyClZXzsd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[mG|ZXSgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwJF0hOC5yMEW1JO69VS5? MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjF6MEizO{c,OjJzOEC4N|c9N2F-
MCF10CA1a NE\kSFNCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M{\JS|Mh\GG7cx?= NXPnXXc3SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBGWiCyb4PpeIl3\SCqdX3hckBOS0ZzMFPBNYEh[2WubIOgZYZ1\XJiMzDkZZl{KGK7IGuzTH11cHmvaXTpcoUhfXC2YXvlJIF{e2G7LDDJR|UxKD1iMD6wNFYzKM7:TT6= MonnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJzOEC4N|coRjJ{MUiwPFM4RC:jPh?=
HL60 NIPJZZNHfW6ldHnvckBie3OjeR?= NX3MRVkzQTZiaILz MYHB[49vcXO2IHHjeIl3cXS7IHH0JHZFWiCrbjDoeY1idiCKTE[wJINmdGy|IHHzd4V{e2WmIHHzJIlv\HWldHnvckBw\iClZXzsJIRq\m[ncnXueIlifGmxbjDh[pRmeiB7NjDodpMh[nliTlLUJIF{e2G7LDDFR|UxKD1iMD6wNFkh|ryPLh?= NFf3Vnc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUWxPFMyQSd-Mkm1NVg{OTl:L3G+
HL-60 MlvrSpVv[3Srb36gZZN{[Xl? MlHCPVYhcHK| MUjB[49vcXO2IHHjeIl3cXS7IHH0JJZqfGGvaX6gSFMhemWlZYD0c5IhcW5iaIXtZY4hUExvNkCgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5lfWO2aX;uJI9nKGOnbHyg[Iln\mW{ZX70bYF1cW:wIHHmeIVzKDl4IHjyd{BjgSCQQmSg[JlmNWKjc3XkJI1q[3Kxc3PvdIlkKGGwYXz5d4l{NCCHQ{WwJF0hOC5yMEmg{txONg>? M{\jOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NU[yOVQzLz5{NkW2NlU1OjxxYU6=
THP1 MnXKSpVv[3Srb36gZZN{[Xl? NXS2OWtzSWO2aY\heIlwdiCxZjDWSHIhcW5iaIXtZY4hXEiSMTDj[YxteyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckAzPS2qeXTyc5h6fmm2YX3pckBFNTJ2LXj5[JJwgHmuYYPlJI1TVkFiZYjwdoV{e2mxbjDifUBTXC2SQ2KsJGVEPTBiPTCwMlAyKM7:TT6= NHTLeXA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUOwPVE2PSd-MUmzNFkyPTV:L3G+
THP1 NF:5XpFHfW6ldHnvckBie3OjeR?= NIjGTJlC[3SrdnH0bY9vKG:oIG\EVkBqdiCqdX3hckBVUFBzIHPlcIx{KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJINifGinbHnjbYRqdiCjboTpcYlkem:kaXHsJJBmeHSrZHWgcXJPSSCneIDy[ZN{cW:wIHL5JHJVNVCFUjygSWM2OCB;IECuNFEh|ryPLh?= M3;LflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7M{C5NVU2Lz5zOUOwPVE2PTxxYU6=
ROS 17/2.8 MkHMSpVv[3Srb36gZZN{[Xl? M4HQcWVn\mWldHn2[UBld3OnIH\vdkB1emGwc3PybZB1cW:wYXygZYN1cX[jdHnvckBqdiCUT2OgNVcwOi56IH;zeIVwe2G{Y3;tZUBk\WyuczygSWQ2OCB;IECuNFEh|ryPLh?= NIDGTJo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMEi5N|MxQSd-MUC4PVM{ODl:L3G+
HL60 MmrOSpVv[3Srb36gZZN{[Xl? NUjZcW1mOTR2IHjydy=> NUSyfFUxUW6mdXP0bY9vKG:oIHPlcIwh\GmoZnXy[Y51cWG2aX;uJI9nKGi3bXHuJGhNPjBiY3XscJMhcW6ldXLheIVlKG[xcjCxOFQhcHK|IHL5JHd{fC1zIHT5[UBj[XOnZDDhd5NigSxiSVO1NEA:KDBwMEWg{txONg>? NV7wRWJlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxPFA6OjZpPkK1NVgxQTJ4PD;hQi=>
MCF7 M1f4VGFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NXzOPXBtPzJiaILz MkDXRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPQ1[3JINmdGy|IHHmeIVzKDd{IHjyd{BjgSCdM1jdeIh6dWmmaX7lJIlv[2:{cH;yZZRqd25iYYPzZZktKEWFNUCgQUAxNjB3MjFOwG0v NW[4TpgzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm3N|k3PzJpPkG5O|M6Pjd{PD;hQi=>
bone marrow cells MXLGeY5kfGmxbjDhd5NigQ>? M1fBd|Mh\GG7cx?= MnfJSYZn\WO2IH;uJI9{fGWxY3zhd5Qh\m:{bXH0bY9vKGmwIHTkXUBud3W|ZTDic45mKG2jcoLve{Bk\WyuczDjc{BkfWy2dYLl[EB4cXSqIIDybY1ienlib4P0[Y9kdGG|dIOgZYZ1\XJiMzDkZZl{KHKnbHH0bZZmKHSxIEGtZYxxcGFuIEK1MUhQUCl{REOsJGVEPTBiPTCwMlEh|ryPLh?= NFHBXXc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEWzPVA{PCd-MUi1N|kxOzR:L3G+
HL-60 MU\GeY5kfGmxbjDhd5NigQ>? M{Tke2lvcGmkaYTpc44hd2ZiY3;sc456KG[xcn3heIlwdiCjc4PhfZMhd25iSFytOlAh[2WubIOsJGVFPTBiPTCwMlE{KM7:TT6= NELsSmQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMEi5N|MxQSd-MUC4PVM{ODl:L3G+
Caco2 NGKwU4FHfW6ldHnvckBie3OjeR?= NEXOeHIzPCCqcoO= NY[0S5B{SWO2aY\heIlwdiCxZjDWSHIhcW5iaIXtZY4hS2Glb{KgZ4VtdHNiZYjwdoV{e2mwZzDs[Y51cX[rcnHsJHZFWkVvbIXjbYZmemG|ZTD2[YN1d3JiYYPz[ZN{\WRiYYOgWmRTTS2vZXTpZZRm\CC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkhdWWjc4Xy[YQh[W[2ZYKgNlQhcHK|IHL5JIx2[2moZYLhd4UhfHKjboPjdolxfGmxbnHsJJJmeG:{dHXyJIF{e2G7LDDFR|UxKD1iMD6yNlM1KM7:TT6= MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzB5MEe3PUc,OjdyN{C3O|k9N2F-
HaCaT NYHBdmlSTnWwY4Tpc44h[XO|YYm= MlrMNlQhcHK| NVrH[Vl4SWO2aY\heIlwdiCxZjDWSHIhcW5iaIXtZY4hUGGFYWSgZ4VtdHNiZYjwdoV{e2mwZzDs[Y51cX[rcnHsJHZFWkVvbIXjbYZmemG|ZTD2[YN1d3JiYYPz[ZN{\WRiYYOgWmRTTS2vZXTpZZRm\CC2cnHud4NzcXC2aX;uZYwh[WO2aY\peJkhdWWjc4Xy[YQh[W[2ZYKgNlQhcHK|IHL5JIx2[2moZYLhd4UhfHKjboPjdolxfGmxbnHsJJJmeG:{dHXyJIF{e2G7LDDFR|UxKD1iMD6yOFk4KM7:TT6= MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzB5MEe3PUc,OjdyN{C3O|k9N2F-
HaCaT NGHUc5pHfW6ldHnvckBie3OjeR?= NGDxd4czPCCqcoO= M3PGc3Rz[W6|YXP0bZZifGmxbjDv[kBXTFJiaX6gbJVu[W5iSHHDZXQh[2WubIOgZYZ1\XJiMkSgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3MDC9JFAvOzJzNTFOwG0v MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjN4N{CxPUc,OjZ|NkewNVk9N2F-
MCF-7 MX\GeY5kfGmxbjDhd5NigQ>? Ml35TY5pcWKrdHnvckBw\iClb3zvcpkh\m:{bXH0bY9vKGG|c3H5d{BwdiCPQ1[tO{Bk\WyuczygSWQ2OCB;IECuN|gh|ryPLh?= Mme0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTB6OUOzNFkoRjFyOEmzN|A6RC:jPh?=
CV1 NE\GZ3NHfW6ldHnvckBie3OjeR?= MV\F[oZm[3Rib36gWmRTNW2nZHnheIVlKHS{YX7zZ5JqeHSrb37hcEBi[3Srdnn0fUBqdiCFVkGgZ4VtdHNidILhcpNn\WO2ZXSge4l1cCCqdX3hckBz\WOxbXLpcoFvfCCYRGKsJGVFPTBiPTCwMlQh|ryPLh?= NIjF[4I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNU[xOVU{PCd-MUW2NVU2OzR:L3G+
Caco2 MX7GeY5kfGmxbjDhd5NigQ>? M{joU|I1KGi{cx?= MXXUdoFve2GldHn2ZZRqd25ib3[gWmRTKGmwIHj1cYFvKEOjY3:yJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTBiPTCwMlUyPTJizszNMi=> M1T5S|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4M{[3NFE6Lz5{NkO2O|AyQTxxYU6=
HN12 NUTGSolJSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= M1fTblczKGi{cx?= Mn\NRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKTkGyJINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKGOnbHygcpVu[mW{IHHmeIVzKDd{IHjyd{BjgSCZU2SgZZN{[XluIFnDOVAhRSByLkW1N{DPxE1w MXm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEOzPUc,OjR7MECzN|k9N2F-
L02 MnTRRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NXf5[VVOPDhiaILz MkLjRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCOMEKgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDBwNkeg{txONg>? MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTVzOEOxPUc,Ojl3MUizNVk9N2F-
L02 M2\EemN6fG:2b4jpZ4l1gSCjc4PhfS=> MmXTOFghcHK| MmPOR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUFAzKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCwMlY4KM7:TT6= M13WRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NU[yOVQzLz5{NkW2NlU1OjxxYU6=
Caco2 MkjBRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MUm0PEBpenN? Mm\NRY51cXCxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEOjY3:yJINmdGy|IHHmeIVzKDR6IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSB2LkSg{txONg>? MoX1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ3NkK1OFIoRjJ4NU[yOVQzRC:jPh?=
Caco2 NIDYXnZCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NYnX[4RFPDhiaILz NXXOV3FPSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDZYNwOiClZXzsd{Bi\nSncjC0PEBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gOE41PiEQvF2u M4DVSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NUG4N|E6Lz5{OUWxPFMyQTxxYU6=
MCF7 MonoRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MX60PEBpenN? MWTBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2FRkegZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDVwNUmg{txONg>? MlvBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3MUizNVkoRjJ7NUG4N|E6RC:jPh?=
MCF7 MkjmRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NY\O[Yo1PDhiaILz NF6xPFJCdnSrcH;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVPGO{Bk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iNT62JO69VS5? NFnKbZI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkW2NlU1Oid-Mk[1OlI2PDJ:L3G+
MCF7 MmHvSpVv[3Srb36gZZN{[Xl? MX[xOkBpenN? M{jKe2JqdmSrbnegZYZncW6rdImgeI8hXkSUIHnuJJNkemGvYnzl[EB{cVKQQT30doFve2[nY4Tl[EBpfW2jbjDNR2Y4KGOnbHzzJIF{e2W|c3XkJIF{KGOnbHyg[5Jwf3SqIHnubIljcXSrb36gZpkhdWWjc4XybY5oKHKnZIXjeIlwdiCrbjDCdoRWKGmwY3;ydI9z[XSrb36gZYZ1\XJiMU[gbJJ{KGK7IFXMTXNCNCCLQ{WwJF0hPi52MzFOwG0v MlPqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzOUOyNVYoRjNyMUmzNlE3RC:jPh?=
PC3 MXvBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NUj4PYp7OjRiaILz NH[0VndCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGDDN{Bk\WyuczDh[pRmeiB{NDDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iOT61N{DPxE1w NI\5[Ho9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MEG5N|IyPid-M{CxPVMzOTZ:L3G+
MCF7 M1u2c2FvfGmycn;sbYZmemG2aY\lJIF{e2G7 MlXSNlQhcHK| NF\h[oxCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiMkSgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEGxMlQ{KM7:TT6= MnX4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzOUOyNVYoRjNyMUmzNlE3RC:jPh?=
MCF7 NXPte4NzSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NUXjPFI3PzJiaILz NH\YTXdCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDwdo9tcW[ncnH0bY9vKGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAyOi53IN88UU4> M1q3OVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUK3NVQ6Lz5{NUGyO|E1QTxxYU6=
PC3 NVO0TFExSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= M{DvSVQ5KGi{cx?= MVLBcpRqeG:uaX\ldoF1cX[nIHHjeIl3cXS7IHHnZYlve3RiaIXtZY4hWEN|IHPlcIx{KGGodHXyJFQ5KGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAyPy5{IN88UU4> MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjV4MkW0Nkc,OjZ3NkK1OFI9N2F-
PC3 MoTSRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NUW0cXdrPDhiaILz Mlu3RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCSQ{OgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KE2WVDDhd5NigSxiSVO1NEA:KDF5LkK1JO69VS5? MnjtQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl3MUizNVkoRjJ7NUG4N|E6RC:jPh?=
BxPC3 MnjZRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MXWyOEBpenN? Mne0RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCEeGDDN{Bk\WyuczDh[pRmeiB{NDDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iMkGuNFch|ryPLh?= NV3uN2RORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CxPVMzOTZpPkOwNVk{OjF4PD;hQi=>
PBMC MV3GeY5kfGmxbjDhd5NigQ>? NIfCVGIyOCCwTR?= Ml;yeZAhfG9iODDodpM> NWS2VmJKSWO2aY\heIlwdiCxZjDWSHIhcW5iTGDTMZN1cW23bHH0[YQhcHWvYX6gVGJOSyClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjCyOU1pgWS{b4j5eol1[W2rbjDEMVI1NWi7ZILvfJlt[XOnIH3SUmEh\XiycnXzd4lwdiCjdDCxNEBvVSCjZoTldkB2eHSxIEigbJJ{KGK7IGLUMXBEWg>? M3r5WlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7M{C5NVU2Lz5zOUOwPVE2PTxxYU6=
THP1 M{[wdmZ2dmO2aX;uJIF{e2G7 M3u4cmFkfGm4YYTpc44hd2ZiVlTSJIlvKGi3bXHuJHRJWDFiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gZ4F1cGWuaXPp[IlvKGGwdHntbYNzd2KrYXygdIVxfGmmZTDtVm5CKGW6cILld5Nqd25iYYSgSWM2OCC3cITvJFUhcHK|IHL5JHJVNVCFUh?= NVewSWN7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmzNFkyPTVpPkG5N|A6OTV3PD;hQi=>
NB4 M1KxPWZ2dmO2aX;uJIF{e2G7 M3vueVEhdk1? MW[0PEBpenN? MYfJcoR2[3Srb36gc4Yh[2WubDDkbYZn\XKnboTpZZRqd25iaX6gbJVu[W5iTlK0JINmdGy|IHHzd4V{e2WmIHHzJIlv\HWldHnvckBw\iCrbnT1Z5Rqd25ib3[gZ4VtdCC|dYLmZYNmKG2jcnvldkBETDF2IHX4dJJme3Orb36gZZQhOSCwTTDh[pRmeiB2ODDodpM> NVTFSYNyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm2PFU5QDhpPkG5Olg2QDh6PD;hQi=>
NB4 NFvFXopHfW6ldHnvckBie3OjeR?= MnHWNUBvVQ>? NFzlboE1QCCqcoO= MU\JcoR2[3Srb36gc4Yh[2WubDDkbYZn\XKnboTpZZRqd25iaX6gbJVu[W5iTlK0JINmdGy|IHHzd4V{e2WmIHHzJIlv\HWldHnvckBw\iCrbnT1Z5Rqd25ib3[gZ4VtdCC|dYLmZYNmKG2jcnvldkBETDFzYjDlfJBz\XO|aX;uJIF1KDFibl2gZYZ1\XJiNEigbJJ{ NES0Sm49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOU[4OVg5QCd-MUm2PFU5QDh:L3G+
HL60 MUjGeY5kfGmxbjDhd5NigQ>? NV\tVGFKPCCmYYnz NF62O|VKdmS3Y4Tpc44hd2ZiY3XscEBlcW[oZYLlcpRq[XSrb36gbY4hcHWvYX6gTGw3OCClZXzsd{Bi\nSncjC0JIRigXNiYomgUmJVKHKnZIXjeIlwdiCjc4PhfS=> MknIQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlzOUOwOVkoRjF7MUmzNFU6RC:jPh?=
HL60 Mn;PSpVv[3Srb36gZZN{[Xl? MnL3NVAh|ryP MXvJcohq[mm2aX;uJI9nKDFuMkWtLG9JMTKGMz3pcoR2[2WmIHPlcIwh\GmoZnXy[Y51cWG2aX;uJIlvKGi3bXHuJGhNPjBiY3XscJMh[XO|ZYPz[YQh[XNibX;ydIhwdG:paXPhcEBkcGGwZ3XzJIF1KDFyJz22JG0h[nliV4Lp[4h1NUenaX3zZUB{fGGrbnnu[y=> MmrFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlzOUOwOVkoRjF7MUmzNFU6RC:jPh?=
SCC4 M33sN2Z2dmO2aX;uJIF{e2G7 MY[xJJVO M1j1UVUhfG9iMUCgcYlvew>? NVT3U|dvSWexbnnzeEBi[3Srdnn0fUBifCCYRGKgbY4hcHWvYX6gV2NEPCClZXzsd{Bie3Onc4Pl[EBieyCrbnT1Z5Rqd25ib3[gR3lROjRiZ3Xu[UBmgHC{ZYPzbY9vKGG2IEGgeW0h[W[2ZYKgOUB1dyBzMDDtbY5{KGK7IGLUMXBEWiCjbnHsfZNqew>? NGPhV4E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MES1NlIzPSd-MkC0OVIzOjV:L3G+
SCC25 MoLvSpVv[3Srb36gZZN{[Xl? NFXmOVYyOCCwTR?= Mmr1RYdwdmm|dDDhZ5Rqfmm2eTDheEBXTFJiaX6gbJVu[W5iU1PDNlUh[2WubIOgZZN{\XO|ZXSgZZMhcW6mdXP0bY9vKG:oIFPZVFI1KGW6cILld5Nqd25iYYSgNVAhdk1? NFT0SlI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEi4N|AzPid-MkC4PFMxOjZ:L3G+
SCC25 MnXVSpVv[3Srb36gZZN{[Xl? NFjnWo8yODBibl2= NIjuSFVC\2:waYP0JIFkfGm4aYT5JIF1KF[GUjDpckBpfW2jbjDTR2MzPSClZXzsd{Bie3Onc4Pl[EBieyCrbnT1Z5Rqd25ib3[gWHNNWCCneIDy[ZN{cW:wIHH0JFExOCCwTR?= MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODh6M{CyOkc,OjB6OEOwNlY9N2F-
C3H10T1/2 NInoUmNHfW6ldHnvckBie3OjeR?= NHHac|IxNjVidH:gOUB2VQ>? M3;6SFI1KGi{cx?= MWTJcohq[mm2aX;uJI9nKEinZHflbI9oKHOrZ37hcIlv\yCyYYToe4F6KGmwIH3veZNmKEN|SEGwWFEwOiClZXzsd{Bie3Onc4Pl[EBieyCmb4fuJJJm\3WuYYTpc44hd2ZiR3zpNUBifCByLkWgeI8hPSC3TTDh[pRmeiB{NDDodpMh[nliUmStVGNTKGGwYXz5d4l{ NGXnbJg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkKyOlY2Pyd-MkKyNlY3PTd:L3G+
HL60 MXrGeY5kfGmxbjDhd5NigQ>? M36z[lEh|ryP M1HqdWlv\HWldHnvckBw\iC4aYThcYlvKERicnXj[ZB1d3JvbXXkbYF1\WRiZHnm[oVz\W62aXH0bY9vKG:oIHj1cYFvKEiONkCgZ4VtdHNiYYSgNVAoNTViTTDifUBPSlRicnXkeYN1cW:wIH3leIhw\A>? NV;VcpdwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyPFU6PDNpPkKyNlg2QTR|PD;hQi=>
HL60 M1jwemZ2dmO2aX;uJIF{e2G7 M1TQXlEhdk1idH:gNVAh|ryP NWjDPWhmUW6mdXP0bY9vKG:oII\peIFucW5iRDDy[YNmeHSxcj3t[YRq[XSnZDDkbYZn\XKnboTpZZRqd25ib3[gbJVu[W5iSFy2NEBk\WyuczDheEAyOCdvOTD0c{AyOCdvNTDNJIJ6KE6EVDDy[YR2[3Srb36gcYV1cG:m NV;vUXM2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyPFU6PDNpPkKyNlg2QTR|PD;hQi=>
A498 Mn3zSpVv[3Srb36gZZN{[Xl? NYjIXJVEOTBibl2= MX:0JIhzew>? NELFVHBKdmS3Y4Tpc44hd2ZiQ2nQNlQhdVKQQTDlfJBz\XO|aX;uJIlvKGi3bXHuJGE1QThiY3XscJMh[XRiMUCnMVghVSCjZoTldkA1KGi{czDifUBTXC2SQ2KgZY5idHm|aYO= NV;UVo1LRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGzPVI6QDNpPkKxN|kzQTh|PD;hQi=>
A498 M33jR2Z2dmO2aX;uJIF{e2G7 NE[0O3IyOCCwTR?= NWK0W5dROTZiaILz NIj3ZmxKdmS3Y4Tpc44hd2ZiQ2nQNlQhdVKQQTDlfJBz\XO|aX;uJIlvKGi3bXHuJGE1QThiY3XscJMh[XRiMUCnMVghVSCjZoTldkAyPiCqcoOgZpkhWlRvUFPSJIFv[Wy7c3nz NVrDXIdjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGzPVI6QDNpPkKxN|kzQTh|PD;hQi=>
DU145 MorXSpVv[3Srb36gZZN{[Xl? MlXaO{42KHWP NFXzfo4yQCCqcoO= NGPD[ndC\2:waYP0JIFkfGm4aYT5JIF1KF[GUj3MRmQhcW5iaIXtZY4hTFVzNEWgZ4VtdHNiYYPz[ZN{\WRiYYOgR3lROjSDMTDlfJBz\XO|aX;uJIF1KDdwNTD1UUBi\nSncjCxPEBpenNiYomgdXJVNVCFUjDt[ZRpd2R? Mn;BQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ5N{S5NlkoRjJ4N{e0PVI6RC:jPh?=
HaCaT MV3GeY5kfGmxbjDhd5NigQ>? NF\N[4dKdmirYnn0bY9vKG:oIHPvcI9vgSCob4LtZZRqd25ib3[gbJVu[W5iSHHDZXQh[2WubIO= NUPmdWtsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK0NFQ{OjZpPkKyOFA1OzJ4PD;hQi=>
HCT116 M1jX[GZ2dmO2aX;uJIF{e2G7 NX7CbHhEOjBidH:gOFAhfU1? M2\oWVI1KGi{cx?= MlvzRYdwdmm|dDDhZ5Rqfmm2eTDheEBTSVJiKIXub45wf25ib4Lp[4lvMSCneIDy[ZN{\WRiaX6gbJVu[W5iSFPUNVE3KGOnbHzzJINwNWW6cILld5NqdmdiUlHSSUBifCB{MDD0c{A1OCC3TTDh[pRmeiB{NDDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5 MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzJ5NkS0PUc,OjN{N{[0OFk9N2F-
HCT116 NVj5S2l5TnWwY4Tpc44h[XO|YYm= MmjoNlAhfG9iNECgeW0> MXyyOEBpenN? NWnqN3MxSWexbnnzeEBi[3Srdnn0fUBifCCUWGKgLJVvc26xd36gc5Jq\2mwKTDlfJBz\XO|ZXSgbY4hcHWvYX6gTGNVOTF4IHPlcIx{KGOxLXX4dJJme3OrbnegVnhTTSCjdDCyNEB1dyB2MDD1UUBi\nSncjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6 NGrnTGs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{K3OlQ1QSd-MkOyO|Y1PDl:L3G+
HEK293 NXP2[pFGTnWwY4Tpc44h[XO|YYm= M3:xSFExOCCwTR?= NGPL[3QzPCCqcoO= MVjJcoR2[3Srb36gc4Yh[3myMkTBNUBuWk6DIHX4dJJme3Orb36gbY4hUEWNMkmzJINmdGy|IHH0JFExOCCwTTDh[pRmeiB{NDDodpMh[nlicnXhcE11cW2nIGDDVi=> Mo\0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5N{O1OlUoRjJ2N{ezOVY2RC:jPh?=
HEK293 NETxN3JHfW6ldHnvckBie3OjeR?= M1jkNlExKG6P NGjERm5VemGwc3HjeIl3[XSrb36gc4YhcHWvYX6gWmRTKERzNEnBJI12fGGwdDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHPv[ZhxemW|c3nu[{BEYVB|QUSgZZQhOTBibl2gZpkh\HWjbDDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZk> M{nu[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEG4PFU4Lz5{NEixPFg2PzxxYU6=
HEK293 M3LUV2Z2dmO2aX;uJIF{e2G7 NFjtbXAyOCCwTR?= M3Hqe3Rz[W6|YXP0bZZifGmxbjDv[kBpfW2jbjDWSHIhUzJ2MFGgcZV1[W62IHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiY3;lfJBz\XO|aX7nJGN[WDODNDDheEAyOCCwTTDifUBlfWGuIHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfS=> MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDhzOEi1O{c,OjR6MUi4OVc9N2F-
MCF7 MY\BcpRqfHWvb4KgZZN{[Xl? MoeyNE42KG2pL3vn NWLaOGlHOyC5ZXXrdy=> NW\QT4JvSW62aYT1cY9zKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{B5\W6xZ4Lh[pRm\CCrbjDCZYxjN2NiboXk[UBud3W|ZTDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCyMkGg[ZhxemW|c3nvckBifCByLkWgcYcwc2duIHnwJIFldWmwaYP0[ZJm\CC2aILl[UB1cW2nczDhJJdm\WtiZn;yJJRpemWnIIfl[Yt{KHO2YYL0bY5oKG[{b32g[IF6KDdiYX\0[ZIhfHWvb4KgZ4VtdCCrbn;jeYxifGmxbjDifUBqdW23bn;obZN1d2OqZX3pZ4FtKGGw NEXyXmo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MEG5N|IyPid-M{CxPVMzOTZ:L3G+
MCF7 NXS5ZmljSW62aYT1cY9zKGG|c3H5 NVXNdpVZOC53IH3nM4to NXPBWG9HOyC5ZXXrdy=> NF2xXW9CdnSrdIXtc5Ih[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJJhmdm:pcnHmeIVlKGmwIFLhcIIw[yCwdXTlJI1wfXOnIHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKHB{NzDlfJBz\XO|aX;uJIF1KDBwNTDt[{9s\yxiaYCgZYRucW6rc4TldoVlKHSqcnXlJJRqdWW|IHGge4VmcyCob4KgeIhz\WVid3Xlb5Mhe3SjcoTpcoch\nKxbTDkZZkhPyCjZoTldkB1fW2xcjDj[YxtKGmwb3P1cIF1cW:wIHL5JIludXWwb3jpd5Rw[2inbXnjZYwh[W5? MlXuQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzBzOUOyNVYoRjNyMUmzNlE3RC:jPh?=
MCF7 MVvBcpRqfHWvb4KgZZN{[Xl? MVuwMlUhdWdxa3e= NHXVPIM{KHenZXvz MXLBcpRqfHWvb4KgZYN1cX[rdImgZYdicW6|dDDoeY1idiCPQ1[3JINmdGy|IIjlco9oemGodHXkJIlvKEKjbHKvZ{BvfWSnIH3veZNmKGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckB1fW2xcjDndo94fGhiYYSgNE42KG2pL3vnMEBqeCCjZH3pcol{fGW{ZXSgeIhz\WVidHnt[ZMh[SC5ZXXrJIZweiC2aILl[UB4\WWtczDzeIFzfGmwZzDmdo9uKGSjeTC3JIFnfGW{IIT1cY9zKGOnbHygbY5w[3WuYYTpc44> MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF7M{KxOkc,OzBzOUOyNVY9N2F-
MCF7 MnLIRY51cXS3bX;yJIF{e2G7 NVvDTmVSOC53IH3nM4to MWGzJJdm\Wu| MkXSRY51cXS3bX;yJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVPGO{Bk\WyuczD4[Y5w\3KjZoTl[EBqdiCEYXziM4MhdnWmZTDtc5V{\SCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckBD[XhiZYjwdoV{e2mxbjDheEAxNjVibXevb4ctKGmyIHHkcYlvcXO2ZYLl[EB1cHKnZTD0bY1meyCjIIfl[Ysh\m:{IITodoVmKHenZXvzJJN1[XK2aX7nJIZzd21iZHH5JFch[W[2ZYKgeJVud3JiY3XscEBqdm:ldXzheIlwdiCkeTDpcY12dm:qaYP0c4Np\W2rY3HsJIFv MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODF7M{KxOkc,OzBzOUOyNVY9N2F-
C3H10T1/2 MVXGeY5kfGmxbjDhd5NigQ>? MlH0NE42KHWP MojpNlQhcHK| M1O0TGFkfGm4YYTpc44hd2ZiaHXk[4Vpd2dic3nncoFtcW6pIIDheIh4[XliaX6gco9vNXSjcnfleIlv\yC|aWLORUB1emWjdHXkJI1wfXOnIFOzTFExXDFxMjDj[YxteyCjc4Pld5Nm\CCjczDl[oZm[3Rib36gWmRTKGW6cILld5Nqd25iYYSgNE42KHWPIHHmeIVzKDJ2IHjyd{BjgSCzUFPSJIFv[Wy7c3nz M1jze|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{OwPVg1Lz5{NEezNFk5PDxxYU6=
C3H10T1/2 MnXvSpVv[3Srb36gZZN{[Xl? NF\PZW8xNjVidV2= MXuyOEBpenN? NFnl[W5C[3SrdnH0bY9vKG:oIHjl[IdmcG:pIIPp[45idGmwZzDwZZRpf2G7IHnuJHZFWi2tbn;jb4Rwf25ibX;1d4UhSzOKMUDUNU8zKGOnbHzzJIF{e2W|c3XkJIF{KGWoZnXjeEBwdiCYRGKg[ZhxemW|c3nvckBifCByLkWgeW0h[W[2ZYKgNlQhcHK|IHL5JJFRS1JiYX7hcJl{cXN? NV;FW4lsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3N|A6QDRpPkK0O|MxQTh2PD;hQi=>
C3H10T1/2 Mm\KSpVv[3Srb36gZZN{[Xl? Mn6yNE42KHWP NV;pcWdkOjRiaILz MXrF[oZm[3Rib36gR3lROjSDMTDSUmEhdGW4ZXygbY4hdm:wLYThdodmfGmwZzDzbXJPSSC2cnXheIVlKG2xdYPlJGM{UDFyVEGvNkBk\WyuczDheEAxNjVidV2gZYZ1\XJiMkSgbJJ{KGK7IIHQR3Ih[W6jbInzbZM> NV3rO3NtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3N|A6QDRpPkK0O|MxQTh2PD;hQi=>
C3H10T1/2 MnXuSpVv[3Srb36gZZN{[Xl? NIrkcWIxNjVidV2= MYmyOEBpenN? NYLTbWhUUW6qaXLpeIlwdiCxZjDo[YRo\WixZzDzbYdv[WyrbnegdIF1cHejeTDpckBvd25vdHHy[4V1cW6pIIPpVm5CKHS{ZXH0[YQhdW:3c3WgR|NJOTCWMT:yJINmdGy|IHHzd4V{e2WmIHHzJIVn\mWldDDvckBXTFJiZYjwdoV{e2mxbjDheEAxNjVidV2gZYZ1\XJiMkSgbJJ{KGK7IIHQR3Ih[W6jbInzbZM> MlvHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5M{C5PFQoRjJ2N{OwPVg1RC:jPh?=
C3H10T1/2 NFWzcZdHfW6ldHnvckBie3OjeR?= MXSwMlUhfU1? MWGyOEBpenN? M{T6dGlvcGmkaYTpc44hd2ZiaHXk[4Vpd2dic3nncoFtcW6pIIDheIh4[XliaX6gWmRTNWuwb3Pr[I94diCvb4Xz[UBEO0hzMGSxM|Ih[2WubIOgZZN{\XO|ZXSgZZMh\W[oZXP0JI9vKF[GUjDlfJBz\XO|aX;uJIF1KDBwNTD1UUBi\nSncjCyOEBpenNiYomgdXBEWiCjbnHsfZNqew>? NUPCNYNGRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3N|A6QDRpPkK0O|MxQTh2PD;hQi=>
LX2 MoXESpVv[3Srb36gZZN{[Xl? M13HeVExOCCwTR?= MUOyOEBpenN? M1jFVnRz[W6|YXP0bZZifGmxbjDv[kBXTFJiaX6gbJVu[W5iTGiyJINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiVFfGZoV1[TFvaX7keYNm\CCFT1yxRVEhdVKQQTDlfJBz\XO|aX;uJIF1KDFyMDDuUUBi\nSncjCyOEBpenNiYomgVU1RS1JiYX7hcJl{cXN? M{nBclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyM{WwPVk6Lz5|MEO1NFk6QTxxYU6=
ROS 17/2.8 NEfpco5HfW6ldHnvckBie3OjeR?= NFnWdoQyPiCqcoO= MoLXTY5lfWO2aX;uJI9nKF[GUjD0doFve2O{aYD0bY9v[WxiYXP0bZZqfHliYYPz[ZN{\WRiYYOgZYN1cX[jdHnvckBw\iB{ND3ofYRzd3i7bHHz[UBo\W6nIHX4dJJme3Orb36gbY4hemG2IGLPV{AyPy9{LkigZ4VtdHNiYX\0[ZIhOTZiaILzJIJ6KGy3Y3nm[ZJie2VicnXwdpRmeiCjc4PhfS=> Mne1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ3N{S5NlEoRjJ4NUe0PVIyRC:jPh?=
HL60 NFvGbY9HfW6ldHnvckBie3OjeR?= NH3JVJM{OCC2bzCxNFAxKG6P NV7YNXRbPDhiaILz M4PsRmlv\HWldHnvckBw\iClZXzsJIRq\m[ncnXueIlifGmxbjDpckBpfW2jbjDIUFYxKGOnbHzzJIF{e2W|c3XkJIF{KG2jdIXybY5oKG2xcoDoc4xw\2mlYXygZ4hidmenczDheEA{OCC2bzCxNFAxKG6PIHHmeIVzKDR6IHjyd{BjgSCZcnnnbJQoey2JaXXtd4Ehe3SjaX7pcocu[mG|ZXSg[o9zfHlibXnjdo9{[2:yaXOgeolmfyCjc4PhfS=> MlnzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzMkexOFkoRjJ3MUK3NVQ6RC:jPh?=
SW480-ADH NUPlSGRETnWwY4Tpc44h[XO|YYm= Mn\TNVAxKG6P NF;zXXc1QCCqcoO= MoLtTY5lfWO2aX;uJI9nKGi3bXHuJHNYPDhyLVHETEBk\WyuIHTp[oZmemWwdHnheIlwdiCjc4Pld5Nm\CCjczDmc5Ju[XSrb36gc4Yh[2:vcHHjeEBmeGm2aHXsbY9q\CCrc3zhcoR{KG:oIHjp[4htgSCjZHjldoVvfCClZXzsd{BifCBzMDCnMVchVSCjZoTldkA1QCCqcoOgZpkheGijc3WtZ49vfHKjc4SgcYlkem:|Y3;wfS=> MlnNQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ7OEmzO|koRjJ{OUi5N|c6RC:jPh?=
SW480-ADH M1PyW2Z2dmO2aX;uJIF{e2G7 NHjKcmoyOCCwTR?= NEnwWm81QCCqcoO= NIj5UXVKdmS3Y4Tpc44hd2ZiaIXtZY4hW1d2OECtRWRJKGOnbHyg[Iln\mW{ZX70bYF1cW:wIHHzd4V{e2WmIHHzJIZwem2jdHnvckBw\iClb33wZYN1KGWyaYTo[Yxqd2mmIHnzcIFv\HNib3[gbIlocGy7IHHkbIVz\W62IHPlcIx{KGG2IEGwJEcuQCCPIHHmeIVzKDR6IHjyd{BjgSCyaHHz[U1kd262cnHzeEBucWO{b4Pjc5B6 MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjl6OUO3PUc,OjJ7OEmzO|k9N2F-
MCF7 NFHUVmFCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= MYWxNFAhdk1? MW[0PEBpenN? NEixV4hCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZZQhOTBiJz23JG0h[W[2ZYKgOFghcHK|IHL5JG1VXCCjc4PhfUBz\WyjdHn2[UB1dyC3boTy[YF1\WRvY3;ueJJwdA>? NVHGfJpURGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK5PFk{PzlpPkKyPVg6Ozd7PD;hQi=>
CLL M{\U[2Z2dmO2aX;uJIF{e2G7 NGjVSmsyODBibl2= MmHBNlQhcHK| NVzGfmlFTW[oZXP0JI9vKEO\UEK0RVEhcW5iaIXtZY4heHKrbXHyfUBEVExiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gWmRTNXKnZ4XsZZRm\CCJQVTEOFVidHCqYTDtVm5CKGW6cILld5Nqd25iYYSgNVAxKG6PIHnuZ5Vj[XSnZDDmc5IhOjRiaILzJIJ6KHG3YX70bZRifGm4ZTDSWE1RS1JibXX0bI9l NEXHdo89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG0PFM6Oid-MkWxOFg{QTJ:L3G+
CLL NHvZdpZHfW6ldHnvckBie3OjeR?= MYKxNFAhdk1? NVnUd3FoOjRiaILz MY\F[oZm[3Rib36gR3lROjSDMTDpckBpfW2jbjDwdolu[XK7IFPMUEBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCYRGKtdoVofWyjdHXkJGNFU05zQTDtVm5CKGW6cILld5Nqd25iYYSgNVAxKG6PIHnuZ5Vj[XSnZDDmc5IhOjRiaILzJIJ6KHG3YX70bZRifGm4ZTDSWE1RS1JibXX0bI9l Mn7qQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNEizPVIoRjJ3MUS4N|kzRC:jPh?=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
CyclinD1 ; 

PubMed: 28643892     


Immunoblot analysis of cyclinD1 in AXT cells treated with the indicated concentrations of calcitriol for 14 h. 

IRE1α / p-eIF2α / eIF2α / Atf4 / CHOP ; 

PubMed: 28643892     


Immunoblot analysis of Ire1a and total or phosphorylated (p-) forms of eIf2a, Atf4 and Chop in AXT cells treated with 5 lM calcitriol for the indicated times.

p-PERK / PERK ; 

PubMed: 28643892     


Immunoblot analysis of total or phosphorylated (p-) forms of Perk and Atf4 in AXT cells treated with 5 lM calcitriol for the indicated times or with 1 lM thapsigardin (Thap) for 1.5 h.

FGFR1 / FGFR2 / FGFR3 / FGFR4 ; 

PubMed: 29776409     


Representative immunoblots and average data (n = 6) of FGFR1, FGFR2, FGFR3, and FGFR4 from control and calcitriol (1 and 10 nM)-treated HL-1 cells.

Wnt10b / Wnt16 ; 

PubMed: 30149605     


Wnt10b and Wnt 16 protein expression in calcitriol-treated osteoclasts. With calcitriol treatment of 10 to 100 nM overnight, Western blot analysis showed a significant increase in Wnt 10b expression. Wnt 16 expression in osteoclasts after different doses of calcitriol was not significantly different at the protein level. Actin protein served as a loading control. 

28643892 29776409 30149605

Protocol

Solubility (25°C)

In vitro DMSO 83 mg/mL (199.21 mM)
Water Insoluble
Ethanol ''83 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 416.64
Formula

C27H44O3

CAS No. 32222-06-3
Storage 3 years -20°C powder
Synonyms RO215535, Topitriol, 1,25-Dihydroxyvitamin D3
Smiles CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04551170 Recruiting Drug: Theophylline|Drug: Placebo Pseudohypoparathyroidism|Albright Hereditary Osteodystrophy|Pseudohypoparathyroidism Type 1a Vanderbilt University Medical Center July 13 2020 Phase 2
NCT03029429 Recruiting Drug: Theophylline|Drug: Placebos Pseudohypoparathyroidism|Albright Hereditary Osteodystrophy Vanderbilt University Medical Center|Harvard University September 1 2018 Phase 2
NCT02714361 Completed Dietary Supplement: Vitamin D3 supplement|Other: Placebo Iron Deficiency|Anemia; Deficiency Nutritional With Poor Iron Absorption|Vitamin D Deficiency University of Chester|Medical Research Council September 2015 Not Applicable

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field
Tags: buy Calcitriol | Calcitriol ic50 | Calcitriol price | Calcitriol cost | Calcitriol solubility dmso | Calcitriol purchase | Calcitriol manufacturer | Calcitriol research buy | Calcitriol order | Calcitriol mouse | Calcitriol chemical structure | Calcitriol mw | Calcitriol molecular weight | Calcitriol datasheet | Calcitriol supplier | Calcitriol in vitro | Calcitriol cell line | Calcitriol concentration | Calcitriol nmr
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID